News

Our facility is closed on Monday June 1st, 2020 because of Whit Monday. We will re-open on Tuesday June 2nd.

We hope that everyone is remaining healthy during the SARS-CoV-2 outbreak. At Future Diagnostics, we work on tomorrow’s healthcare projects. That is what makes our work interesting. Especially at this time when healthcare is being challenged like this.

At Future Diagnostics, safety and well-being of our employees and customers are our top priority.

Given the intense focus on steps being taken by organizations to halt the spread of the virus, we would like to update you on Future Diagnostics policy in relation to the services we offer to you as a customer or other stakeholder.

We are very proud that Future Diagnostics Solutions is recognized by MedTech Outlook Magazine as TOP 10 In Vitro Diagnostic Solution Provider in Europe – 2020.

Future Diagnostics is proudly announcing the PhD promotion of Giuliana Ascone. Giuliana was ESR in the Marie Curie Euroclast project supported by Future Diagnostics and working at the Department of Experimental Rheumatology of the Radboud University.

Future Diagnostics Solutions B.V. is proud to announce the successful completion of its fifth Food and Drug Administration (FDA) inspection last month. The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices.

Sensing technologies for acquiring real-time, precise, and reliable data are becoming more and more important in the field of healthcare, to help monitor, treat and coach patients. Future Diagnostics Solutions is proud to be a partner in the TTW funded Biomonitor project aiming at the development of continuous monitoring sensors.

After last year’s successful edition we are proud to be organizing our second IVDR & Immunoassays Mini Symposium on Wednesday November 20th, 2019 from 9 am to 10.30 am at MEDICA.